Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) vs Scheme for Strengthening of Pharmaceuticals Industry (SPI)
An objective, data-backed comparison of benefits, eligibility restrictions, paperwork requirements, and official application portals for Indian citizens.
Analytical Overview & Comparative Assessment
While both Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and Scheme for Strengthening of Pharmaceuticals Industry (SPI) serve public welfare in India, they differ significantly in their operational framework, benefit distribution models, and target beneficiary thresholds. Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) operates at the central tier focusing on World largest government-funded health assurance scheme providing ₹5 lakh annual cashless health cover per family for secondary and tertiary care hospitalization., whereas Scheme for Strengthening of Pharmaceuticals Industry (SPI) operates at the central tier providing Central sector umbrella scheme providing capital and interest subsidies to MSME pharma enterprises for upgrading quality standards (Schedule M / WHO-GMP) and setting up common testing centers..
Prospective applicants must carefully evaluate domicile mandates, annual family income ceilings, and documentary evidence before initiating applications on the respective official nodal portals.
Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY): central
Scheme for Strengthening of Pharmaceuticals Industry (SPI): central
Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY): Health assurance cover of ₹5,00,000 per family per year on a family floater...
Scheme for Strengthening of Pharmaceuticals Industry (SPI): Capital subsidy of up to 20% (ceiling Rs. 2 Crore) or interest subvention o...
Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY): ₹2,50,000/yr
Scheme for Strengthening of Pharmaceuticals Industry (SPI): No ceiling
Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY): 3 verified docs
Scheme for Strengthening of Pharmaceuticals Industry (SPI): 3 verified docs
Which Scheme Is Right for You?
- You meet the age criteria of any age bracket.
- Your family annual income is below ₹2,50,000.
- You are seeking entitlements specifically designed for World largest government-funded health assurance scheme providing ₹5 lakh annual cashless health cover per family for secondary and tertiary care hospitalization..
- You have ready access to all 3 mandatory identity and domicile documents.
- You meet the age criteria of any age bracket.
- Your family annual income is within general limits (no gross cap).
- You require public benefits tailored around Central sector umbrella scheme providing capital and interest subsidies to MSME pharma enterprises for upgrading quality standards (Schedule M / WHO-GMP) and setting up common testing centers..
- You can provide the 3 official verification documents mandated by the nodal ministry.
Side-by-Side Detailed Specifications Matrix
Direct parameter comparison verified against current official guidelines and statutory gazettes.
| Comparison Factor | Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) | Scheme for Strengthening of Pharmaceuticals Industry (SPI) |
|---|---|---|
| Jurisdiction Level | central Scheme | central Scheme |
| Operational Status | active | active |
| Benefits & Entitlement | Health assurance cover of ₹5,00,000 per family per year on a family floater basis for secondary and tertiary care hospitalization across 27,000+ empanelled public and private hospitals nationwide. Includes 3 days of pre-hospitalization and 15 days of post-hospitalization expenses, diagnostic tests, surgeries, and medications. Cashless and paperless treatment at point of care. All senior citizens aged 70 and above, regardless of income, receive a distinct top-up cover of ₹5,00,000 per year under the Ayushman Vay Vandana card. | Capital subsidy of up to 20% (ceiling Rs. 2 Crore) or interest subvention of up to 6% per annum for technology upgradation under PTUAS (Pharmaceutical Technology Upgradation Assistance Scheme). Capital grant of up to 70% (ceiling Rs. 20 Crore) for creating Assistance to Pharmaceutical Industry for Common Facilities (APCF). Financial support of up to Rs. 1 Crore for pharmaceutical clusters for research, testing laboratories, and environmental effluent treatment plants. |
| Age Bracket | No age limit | No age limit |
| Income Limit | ₹2,50,000/yr | No gross ceiling |
| Eligible Occupations | informal_worker, daily_wage_worker, driver, construction_worker, domestic_worker, artisan, street_vendor, agricultural_laborer, unemployed | Pharma MSME entrepreneurs, pharmaceutical laboratory owners |
| Social Categories | BPL, SC, ST, OBC, EWS | all |
| Required Documents | 3 verified documents | 3 verified documents |
| Official Outbound CTA | Apply for Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) ↗ | Apply for Scheme for Strengthening of Pharmaceuticals Industry (SPI) ↗ |
How to Choose — Decision Framework
AChoose Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) if you:
- →Have annual income below ₹2,50,000
- →Are applying from anywhere in India (All-India scheme)
- →Can provide 3 required documents
BChoose Scheme for Strengthening of Pharmaceuticals Industry (SPI) if you:
- →Are applying from anywhere in India (All-India scheme)
- →Can provide 3 required documents
Can You Claim Both Simultaneously?
Both schemes operate at the central level. Dual enrollment is subject to individual scheme guidelines — check each scheme's official portal to confirm non-conflicting eligibility. Many welfare programs explicitly permit convergence. Check Combined Eligibility →
Frequently Asked Questions: Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) vs Scheme for Strengthening of Pharmaceuticals Industry (SPI)
Can an eligible citizen claim benefits under both Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and Scheme for Strengthening of Pharmaceuticals Industry (SPI) simultaneously?
Dual enrollment depends on scheme scopes and DBT (Direct Benefit Transfer) duplicate-benefit restrictions. If the two schemes address distinct needs (e.g. higher education aid combined with agricultural input support), eligible applicants can generally receive both. However, where both programs provide overlapping subsidies for the identical welfare objective, PFMS Aadhaar de-duplication will restrict dual claims. Verify the individual nodal guidelines before submitting applications.
What are the primary differences in eligibility between Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and Scheme for Strengthening of Pharmaceuticals Industry (SPI)?
Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) is a central program with specific income ceilings, target occupations, and required documentation. Meanwhile, Scheme for Strengthening of Pharmaceuticals Industry (SPI) is a central initiative with distinct qualification criteria. Review the detailed side-by-side matrix on this page to compare age caps, income limits, and eligible beneficiary categories.
Where should applications for Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and Scheme for Strengthening of Pharmaceuticals Industry (SPI) be submitted?
All applications must be filed exclusively through authorized government portals ending in .gov.in or .nic.in. For Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), access https://beneficiary.nha.gov.in. For Scheme for Strengthening of Pharmaceuticals Industry (SPI), access https://pharmaceuticals.gov.in/schemes. Eligo is an independent research platform and never charges application fees or collects applicant login credentials.
How many supporting documents are required for each scheme?
Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) requires 3 verified supporting documents, whereas Scheme for Strengthening of Pharmaceuticals Industry (SPI) requires 3 verified documents. Ensure your Aadhaar, bank passbook, and category certificates carry matching biographical details across all submissions.
Notice of Independence & Official Verification:
Eligo is an independent civic research directory. All scheme data and comparison parameters are compiled from public gazette notifications, government press releases (PIB), and official ministry guidelines. Eligo is not associated with or authorized by any governmental body. Always submit applications directly on verified official portals ending in .gov.in or .nic.in.